These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6965227)

  • 1. Immunoselection of tumor variants resistant to antibody-mediated cytotoxicity. Their immunologic and metastatic characterization.
    Starkey JR; Davis WC; Talmadge JE
    Cancer Immunol Immunother; 1982; 14(2):124-31. PubMed ID: 6965227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor progression in vitro: the paradoxical natural antibody and complement-selected phenotype.
    Chow DA; Chan J
    Nat Immun Cell Growth Regul; 1987; 6(4):189-204. PubMed ID: 3683415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in sensitivity to nonspecific cell-mediated lysis associated with tumor progression: characterization of activated macrophage- and natural killer cell-resistant tumor variants.
    Nestel FP; Casson PR; Wiltrout RH; Kerbel RS
    J Natl Cancer Inst; 1984 Aug; 73(2):483-91. PubMed ID: 6589440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced invasiveness and metastatic potential of epithelial cell lines cultured in the presence of dimethyl sulphoxide.
    Bentel JM; Rhodes GC; Markus I; Smith GJ
    Int J Cancer; 1990 Aug; 46(2):251-7. PubMed ID: 2384274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural cytotoxicity in lymphatic metastasis. II. In vivo studies with BSp73 variants differing in metastatic capacity.
    Matzku S
    Cancer Immunol Immunother; 1984; 17(2):106-11. PubMed ID: 6565517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural cytotoxicity in lymphatic metastasis. I. In vitro studies using the rat tumor BSp73 and its variants.
    Matzku S; Oberneder HP; Keller R; Zöller M
    Cancer Immunol Immunother; 1984; 17(2):100-5. PubMed ID: 6565516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of rat complement control protein Crry on tumor cells inhibits rat natural killer cell-mediated cytotoxicity.
    Caragine TA; Imai M; Frey AB; Tomlinson S
    Blood; 2002 Nov; 100(9):3304-10. PubMed ID: 12384431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of in vitro immunoselected variants from a highly metastatic murine tumor for alterations in malignant behavior in vivo.
    Liteplo RG; Frost P; Donaghue TP; Kerbel RS
    Int J Cancer; 1984 May; 33(5):669-75. PubMed ID: 6724741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vivo lysis of tumor cells of varying degrees of immune resistance].
    Viksler VKh; Ustinov AS
    Eksp Onkol; 1989; 11(3):55-60. PubMed ID: 2752945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-alpha mediated selection of macrophage-resistant gene-regulatory tumor variants.
    Remels L; Neirynck A; Brys L; Vercauteren E; De Baetselier P
    Clin Exp Metastasis; 1989; 7(5):493-506. PubMed ID: 2473862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of naturally occurring triterpenoids ursolic acid and glycyrrhizic acid on the cell-mediated immune responses of metastatic tumor-bearing animals.
    Raphael TJ; Kuttan G
    Immunopharmacol Immunotoxicol; 2008; 30(2):243-55. PubMed ID: 18569082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific and forssman antigens of guinea-pig hepatoma cells: comparison of tumor cells grown in vivo and in vitro.
    Evans CH; Ohanian SH; Cooney AM
    Int J Cancer; 1975 Mar; 15(3):512-21. PubMed ID: 166937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variance in resistance to natural and antibody-dependent cellular cytotoxicity and to complement-mediated lysis among K562 lines.
    Kimber I; Moore M; Roberts K
    Int J Cancer; 1983 Aug; 32(2):219-25. PubMed ID: 6575968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of cloned high- and low-metastatic murine Lewis lung tumor cells to lysis by cytotoxic autoreactive cells.
    Olsson L; Kiger N; Kronstrom H
    Cancer Res; 1981 Nov; 41(11 Pt 1):4706-9. PubMed ID: 6975655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human tumor spontaneous metastasis in immunosuppressed newborn rats. II. Multiple selections of human melanoma metastatic clones and variants.
    Bailly M; Doré JF
    Int J Cancer; 1991 Nov; 49(5):750-7. PubMed ID: 1937961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor progression in metastasis: an experimental approach using lectin resistant tumor variants.
    Kerbel RS; Dennis JW; Largarde AE; Frost P
    Cancer Metastasis Rev; 1982; 1(2):99-140. PubMed ID: 6764377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor progression in vitro: tumor-promoter-induced reversible decrease in natural immune susceptibility.
    Sandstrom PA; Chow DA
    Carcinogenesis; 1988 Nov; 9(11):1967-73. PubMed ID: 3180334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curculigoside augments cell-mediated immune responses in metastatic tumor-bearing animals.
    Murali VP; Kuttan G
    Immunopharmacol Immunotoxicol; 2016 Aug; 38(4):264-9. PubMed ID: 27228189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic enhancement of experimental metastasis in the rat.
    Starkey JR; Ristow SS; McDonald TL; Talmadge JE
    Cancer Immunol Immunother; 1984; 17(1):42-50. PubMed ID: 6563943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoselection in vitro of a non-metastatic variant from a highly metastatic tumor.
    Frost P; Kerbel RS
    Int J Cancer; 1981 Mar; 27(3):381-5. PubMed ID: 7287222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.